Reference
Medications Containing Semaglutide Marketed for Type 2 Diabetes or Weight Loss Internet Document : 31 May 2023. Available from: URL: https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/medications-containing-semaglutide-marketed-type-2-diabetes-or-weight-loss
Rights and permissions
About this article
Cite this article
Adverse events after use of compounded semaglutide. Reactions Weekly 1961, 1 (2023). https://doi.org/10.1007/s40278-023-41258-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-41258-x